骨形态发生蛋白信号传导对骨科疾病的影响及应用研究进展(5)
[27]Lotinun S，Pearsall RS，Davies MV，et al.A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys[J].Bone，2010，46(4)：1082–1088.
[28]Lotinun S，Pearsall RS，Horne WC，et al.Activin receptor signaling： a potential therapeutic target for osteo-porosis[J].Current Molecular Pharmacology，2011，5(2)：195-204.
[29]Kaneki H，Guo R，Chen D，et al.Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts[J].Journal of Biological Chemistry，2006，281(7)：4326–4333.
[30]Garrett IR，Chen D，Gutierrez G，et al.Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro[J].Journal of Clinical Investigation，2003，111(11)：1771–1782.
[31]Zangari M，Terpos E，Zhan F，et al.Impact of bortezomib on bone health in myeloma： a review of current evidence[J].Cancer Treatment Reviews，2012，38(8)：968-980.
[32]Marie PJ，Kassem M.Osteoblasts in osteoporosis：past，emerging，and future anabolic targets[J].Eur J of Endocrinol，2011，165：1–10., 百拇医药(杨少辉 许红霞 乔志芬)
[28]Lotinun S，Pearsall RS，Horne WC，et al.Activin receptor signaling： a potential therapeutic target for osteo-porosis[J].Current Molecular Pharmacology，2011，5(2)：195-204.
[29]Kaneki H，Guo R，Chen D，et al.Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts[J].Journal of Biological Chemistry，2006，281(7)：4326–4333.
[30]Garrett IR，Chen D，Gutierrez G，et al.Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro[J].Journal of Clinical Investigation，2003，111(11)：1771–1782.
[31]Zangari M，Terpos E，Zhan F，et al.Impact of bortezomib on bone health in myeloma： a review of current evidence[J].Cancer Treatment Reviews，2012，38(8)：968-980.
[32]Marie PJ，Kassem M.Osteoblasts in osteoporosis：past，emerging，and future anabolic targets[J].Eur J of Endocrinol，2011，165：1–10., 百拇医药(杨少辉 许红霞 乔志芬)